XX Chapter

One day. No fluff. Every seat in this room earned its place.

Purchase Pass

Purchase Pass

May 7

May 7

2026

2026

San Jose Convention Center

San Jose Convention Center

California, USA

California, USA

FemTech conference stage at SynBioBeta 2026 featuring women leaders in biotech and health innovation

Who’s Coming to XX Chapter?

logo.png

Purchase Pass

Purchase Pass

Why XX Chapter

XX Chapter is a curated, invitation-caliber gathering inside SynBioBeta 2026 — a room designed for founders, scientists, physicians, investors, and operators building the biological infrastructure of the next century.

Four frontier panels.
One tightly curated day.
No spectators — only contributors.

Who speaks

Speakers selected for scientific credibility and execution track record. No vanity invites — every voice on stage has built, shipped, or discovered something real.

Who's in the Room

Audience filtered for founders, funders, and operators. Closed-room energy inside a global summit. No spectators.

What's on the table

Four panels spanning precision medicine, AI-bio convergence, longevity, reproduction, and neuroengineering. Cross-disciplinary by design.

Architects don't wait for the future. They engineer it.

Purchase XX Chapter Pass

Purchase XX Chapter Pass

Register Now

Register Now

Every Seat Earned Its Place. Here's Who's on Stage.

Laura Hix

Adjuvia

CEO

Liz Swenson

GetTeal

Medical Director

Andrea Diaz

Oncoswab

CEO

Zara Butte

Human Longevity Inc

Physician

Nabiha Saklayan

Cellino Bio

CEO

Juliette Humer

Muse Bio

CEO

Rimma Boshernitzan

In-Dialogue

Futurist and CEO

Lauren Avenius

Node Labs

CEO, AI Drug Discovery Executive

Deena Emera

Buck Institute

Senior Researcher

Maria Lence

For Women's Health

CEO

Carolyn Ng

TPG Life Sciences Innovation

Partner

Duda Franklin

Orby

Founder, Neuro Engineer

Dyvia Chandler

Lucidify

Founder, Physician and Neuroscientist

Viviana Mucci

BreaVital

Founder and Neuroscientist

Melissa Mokrani

Worth Health Studio

Founder and Neuroscience Expert

Stephanie Fine Sasse

The Plenary Co

Founder and Neuroscientist

Sessions Will Include
Femtech

•

12:00 – 12:45 PM Lunch | 12:45 – 1:30 PM Session

Early detection. Precision intervention. Real-world deployment.

From circulating tumor DNA to AI-enabled diagnostics, liquid biopsies are collapsing the distance between biology and clinical action. This chamber convenes the scientists and clinicians leading that collapse — researchers who are not theorizing about the future of oncology, but building it: earlier signals, sharper targeting, smarter monitoring, and interventions that meet patients where the disease actually lives.

Purchase Pass

Featuring

Laura Hix

Adjuvia

CEO

Viola Folli

D-Tails

CSO

Liz Swenson

GetTeal

Medical Director

Andrea Diaz

Oncoswab

CEO

Moderator

Zara Butte

Human Longevity Inc

Physician

Femtech

•

12:00 PM

-

1:30 PM

Early detection. Precision intervention. Real-world deployment.

From circulating tumor DNA to AI-enabled diagnostics, liquid biopsies are collapsing the distance between biology and clinical action. This chamber convenes the scientists and clinicians leading that collapse — researchers who are not theorizing about the future of oncology, but building it: earlier signals, sharper targeting, smarter monitoring, and interventions that meet patients where the disease actually lives.

Purchase Pass

Featuring

Laura Hix

Adjuvia

CEO

Viola Folli

D-Tails

CSO

Liz Swenson

GetTeal

Medical Director

Andrea Diaz

Oncoswab

CEO

Moderator

Zara Butte

Human Longevity Inc

Physician

Femtech

•

1:30 PM

-

2:15 PM

Evidence-Based Longevity

Aging is not a destiny. It is a program. And programs can be rewritten. Epigenetic clocks are now precise enough to measure biological age down to the tissue level. Stem cell engineering is restoring function in systems once thought irreversible. Longevity science — for the first time in its history — has the tools to match its ambitions. This chamber convenes the researchers doing the matching: scientists who have moved past the supplement stacks and the headlines, into the hard, exacting work of understanding what drives cellular aging — and what, with enough precision, can slow it, reverse it, or render it beside the point.

Purchase Pass

Featuring

Nabiha Saklayan

Cellino Bio

CEO

Juliette Humer

Muse Bio

CEO

Turning menstrual blood into scalable stem-cell medicine

Moderator

Rimma Boshernitzan

In-Dialogue

Futurist and CEO

Femtech

•

1:30 PM

-

2:15 PM

Evidence-Based Longevity

Aging is not a destiny. It is a program. And programs can be rewritten. Epigenetic clocks are now precise enough to measure biological age down to the tissue level. Stem cell engineering is restoring function in systems once thought irreversible. Longevity science — for the first time in its history — has the tools to match its ambitions. This chamber convenes the researchers doing the matching: scientists who have moved past the supplement stacks and the headlines, into the hard, exacting work of understanding what drives cellular aging — and what, with enough precision, can slow it, reverse it, or render it beside the point.

Purchase Pass

Featuring

Nabiha Saklayan

Cellino Bio

CEO

Juliette Humer

Muse Bio

CEO

Turning menstrual blood into scalable stem-cell medicine

Moderator

Rimma Boshernitzan

In-Dialogue

Futurist and CEO

Femtech

•

3:30 PM

-

4:15 PM

Engineering Reproduction

From AI-powered drug discovery to genomic selection and ovarian longevity — one of the most technically complex and ethically charged frontiers in biotech. The biology of reproduction has always carried the weight of the human story. Now it carries the weight of the possible. Ovarian aging is being mapped at the molecular level. Genomic selection is moving from research settings into clinical practice. AI is accelerating drug discovery for conditions that have been chronically underfunded and chronically misunderstood. The tools exist. The data is accumulating. The ethical frameworks are being written in real time — by the scientists in this room.

Purchase Pass

Featuring

Lauren Avenius

Node Labs

CEO, AI Drug Discovery Executive

Deena Emera

Buck Institute

Senior Researcher

Maria Lence

For Women's Health

CEO

Moderator

Carolyn Ng

TPG Life Sciences Innovation

Partner

Femtech

•

3:30 PM

-

4:15 PM

Engineering Reproduction

From AI-powered drug discovery to genomic selection and ovarian longevity — one of the most technically complex and ethically charged frontiers in biotech. The biology of reproduction has always carried the weight of the human story. Now it carries the weight of the possible. Ovarian aging is being mapped at the molecular level. Genomic selection is moving from research settings into clinical practice. AI is accelerating drug discovery for conditions that have been chronically underfunded and chronically misunderstood. The tools exist. The data is accumulating. The ethical frameworks are being written in real time — by the scientists in this room.

Purchase Pass

Featuring

Lauren Avenius

Node Labs

CEO, AI Drug Discovery Executive

Deena Emera

Buck Institute

Senior Researcher

Maria Lence

For Women's Health

CEO

Moderator

Carolyn Ng

TPG Life Sciences Innovation

Partner

Femtech

•

4:30 PM

-

5:15 PM

What Future Can We Imagine?

The brain was never static. We just lacked the language to describe its motion. That language now exists. Neuroplasticity is no longer a metaphor for resilience — it is a measurable, targetable biological phenomenon. Metabolic psychiatry is revealing that mental illness is not purely a disorder of neurotransmitters, but of energy, inflammation, and cellular environment. Cognitive engineering is moving from speculative to clinical, from enhancement to intervention, from philosophy to protocol.

Purchase Pass

Featuring

Duda Franklin

Orby

Founder, Neuro Engineer

Dyvia Chandler

Lucidify

Founder, Physician and Neuroscientist

Viviana Mucci

BreaVital

Founder and Neuroscientist

Melissa Mokrani

Worth Health Studio

Founder and Neuroscience Expert

Moderator

Stephanie Fine Sasse

The Plenary Co

Founder and Neuroscientist

Femtech

•

4:30 PM

-

5:15 PM

What Future Can We Imagine?

The brain was never static. We just lacked the language to describe its motion. That language now exists. Neuroplasticity is no longer a metaphor for resilience — it is a measurable, targetable biological phenomenon. Metabolic psychiatry is revealing that mental illness is not purely a disorder of neurotransmitters, but of energy, inflammation, and cellular environment. Cognitive engineering is moving from speculative to clinical, from enhancement to intervention, from philosophy to protocol.

Purchase Pass

Featuring

Duda Franklin

Orby

Founder, Neuro Engineer

Dyvia Chandler

Lucidify

Founder, Physician and Neuroscientist

Viviana Mucci

BreaVital

Founder and Neuroscientist

Melissa Mokrani

Worth Health Studio

Founder and Neuroscience Expert

Moderator

Stephanie Fine Sasse

The Plenary Co

Founder and Neuroscientist

Purchase Pass

Purchase Pass

Join for the latest
SynBioBeta event updates.

Join List

Join List

Purchase Pass

Purchase Pass

Join for the latest SynBioBeta event updates.

Join List

Join List

Purchase Pass

Purchase Pass